Fever Breaking For Momentum Stocks… And Sarepta Surges After FDA Approval 6/21/24
CNBC's "Fast Money"
00:00
Biotech Stock Surge and Bank Weaknesses Discussion
This chapter covers the rise of biotech stocks including Sarepta Therapeutics post-FDA approval and an upcoming interview with the company's CEO. It also touches on tools for traders from sponsor TastyTrade and the pressure on banks from regulatory scrutiny affecting their stock values.
Play episode from 25:20
Transcript
